Selective reduction in cortical bone mineral density in Turner syndrome independent of ovarian hormone deficiency

被引:53
作者
Bakalov, VK
Axelrod, L
Baron, J
Hanton, L
Nelson, LM
Reynolds, JC
Hill, S
Troendle, J
Bondy, CA
机构
[1] NICHHD, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA
[2] NICHHD, Div Epidemiol Stat & Prevent Res, NIH, Bethesda, MD 20892 USA
[3] NIH, Warren G Magnuson Clin Ctr, Dept Radiol, Bethesda, MD 20892 USA
关键词
D O I
10.1210/jc.2003-030913
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Women with Turner syndrome (TS) are at risk for osteoporosis from ovarian failure and possibly from haploinsufficiency for bone-related X-chromosome genes. To establish whether cortical or trabecular bone is predominantly affected, and to control for the ovarian failure, we studied forearm bone mineral density (BMD) in 41 women with TS ages 18 - 45 yr and in 35 age-matched women with karyotypically normal premature ovarian failure (POF). We measured BMD at the 1/3 distal radius (D-Rad(1/3); predominantly cortical bone) and at the ultradistal radius (UD-Rad; predominantly trabecular bone) by dual x-ray absorptiometry. Women with TS had lower cortical BMD compared with POF (D-Rad(1/3) Z-score = -1.5 +/- 0.8 for TS and 0.08 +/- 0.7 for POF; P< 0.0001). In contrast, the primarily trabecular UD-Rad BMD was normal in TS and not significantly different from POF (Z-score = - 0.62 +/- 1.1 for TS and - 0.34 +/- 1.0 for POF; P = 0.26). The difference in cortical BMD remained after adjustment for height, age of puberty, lifetime estrogen exposure, and serum 25-hydroxyvitamin D (P = 0.0013). Cortical BMD was independent of serum IGF-I and - II, PTH, and testosterone in TS. We conclude that there is a selective deficiency in forearm cortical bone in TS that appears independent of ovarian hormone exposure and is probably related to X-chromosome gene(s) haploinsufficiency.
引用
收藏
页码:5717 / 5722
页数:6
相关论文
共 14 条
[1]   Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects [J].
Amato, G ;
Izzo, G ;
LaMontagna, G ;
Bellastella, A .
CLINICAL ENDOCRINOLOGY, 1996, 45 (01) :27-32
[2]   Body fat content and 25-hydroxyvitamin D levels in healthy women [J].
Arunabh, S ;
Pollack, S ;
Yeh, J ;
Aloia, JF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) :157-161
[3]   Bone mineral density and fractures in turner syndrome [J].
Bakalov, VK ;
Chen, ML ;
Baron, J ;
Hanton, LB ;
Reynolds, JC ;
Stratakis, CA ;
Axelrod, LE ;
Bondy, CA .
AMERICAN JOURNAL OF MEDICINE, 2003, 115 (04) :259-264
[4]   Musculoskeletal analyses of the forearm in young women with Turner syndrome: A study using peripheral quantitative computed tomography [J].
Bechtold, S ;
Rauch, F ;
Noelle, V ;
Donhauser, S ;
Neu, CM ;
Schoenau, E ;
Schwarz, HP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (12) :5819-5823
[5]  
CARTER DR, 1992, J BONE MINER RES, V7, P137
[6]   Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea [J].
Davies, MC ;
Gulekli, B ;
Jacobs, HS .
CLINICAL ENDOCRINOLOGY, 1995, 43 (06) :741-746
[7]   Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult Turner syndrome: A cross-sectional study [J].
Gravholt, CH ;
Lauridsen, AL ;
Brixen, K ;
Mosekilde, L ;
Heickendorff, L ;
Christiansen, JS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06) :2798-2808
[8]   SKELETAL SIZE AND BONE-MINERAL CONTENT IN TURNERS SYNDROME - RELATION TO KARYOTYPE, ESTROGEN-TREATMENT, PHYSICAL-FITNESS, AND BONE TURNOVER [J].
NAERAA, RW ;
BRIXEN, K ;
HANSEN, RM ;
HASLING, C ;
MOSEKILDE, L ;
ANDRESEN, JH ;
CHARLES, P ;
NIELSEN, J .
CALCIFIED TISSUE INTERNATIONAL, 1991, 49 (02) :77-83
[9]  
PALMA LD, 1966, RADIOL CLIN, V35, P65
[10]  
ROSEN HN, 1995, J BONE MINER RES, V10, P1352